Quarterly Sector Reports

Life Science Tools & Diagnostics Q3 2022 Sector Report

« Back

Comprehensive sector recap reports provided on a quarterly basis

Gilmartin Group client deliverables include comprehensive sector-based recaps. At the close of Q3 2022, we compiled the recap available through the link summarizing what happened in the LS Tools/Dx sector across a number of topics including Q3 performance, rating changes, sector multiples, short interest, capital raises, shelf filings, M&A transactions, C-Suite and BOD chairman changes, among other things.

Our Clients

Our clients are leaders and innovators across the MedTech, Biotechnology, Digital Health, Life Science Tools & Diagnostic sectors

Learn More About Our Clients

Gilmartin Blog

Gilmartin has a number of resources, from blog posts to webinars designed to educate and help your company achieve success.

Explore Our Blog